Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor.

Puranik, Shriya; Harlow, Christopher; Martin, Laura; Coleman, Meg; Russell, Georgina; Park, Mirae; Min Kon, Onn

Puranik, Shriya; Harlow, Christopher; Martin, Laura; Coleman, Meg; Russell, Georgina; Park, Mirae; Min Kon, Onn.

Afiliação

Puranik S; Imperial College London, Imperial Clinical Respiratory Research Unit (ICRRU), United Kingdom.
Harlow C; Imperial College Healthcare Trust NHS, United Kingdom.
Martin L; Imperial College Healthcare Trust NHS, United Kingdom.
Coleman M; Imperial College Healthcare Trust NHS, United Kingdom.
Russell G; Imperial College Healthcare Trust NHS, United Kingdom.
Park M; Imperial College Healthcare Trust NHS, Imperial Clinical Respiratory Research Unit (ICRRU), National Heart and Lung Institute, Imperial College London, United Kingdom.
Min Kon O; Imperial College Healthcare Trust NHS, National Heart and Lung Institute, Imperial College London, United Kingdom.

J Clin Tuberc Other Mycobact Dis ; 26: 100293, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35146132

Palavras-chave

AliveCor; Cardiotoxic; Mobile health; NTM; QTc; Tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Clin Tuberc Other Mycobact Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google